๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

[The Enzymes] Eukaryotic RNases and their Partners in RNA Degradation and Biogenesis, Part B Volume 32 || Nanoparticle-Based Delivery of siRNA and miRNA for Cancer Therapy

โœ Scribed by Yanes, Rolando E.


Book ID
118238757
Publisher
Elsevier
Year
2012
Tongue
English
Weight
767 KB
Edition
1
Category
Article
ISBN
0124047416

No coin nor oath required. For personal study only.

โœฆ Synopsis


This special volume of The Enzymes is targeted towards researchers in biochemistry, molecular and cell biology, pharmacology, and cancer. This thematic volume discusses Eukaryotic RNases and their partners in RNA degradation and biogenesis.

Key features:

* Contributions from leading authorities

* Informs and updates on all the latest developments in the field


๐Ÿ“œ SIMILAR VOLUMES


[The Enzymes] Eukaryotic RNases and thei
โœ Feng Guo and Fuyuhiko Tamanoi (Eds.) ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Academic Press, Elsevier ๐ŸŒ English โš– 669 KB

This special volume of *The Enzymes* is targeted towards researchers in biochemistry, molecular and cell biology, pharmacology, and cancer. This thematic volume discusses Eukaryotic RNases and their partners in RNA degradation and biogenesis. Key features: \* Contributions from leading auth

[The Enzymes] Eukaryotic RNases and thei
โœ Sato, Kaoru ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Elsevier ๐ŸŒ English โš– 811 KB

This special volume of *The Enzymes* is targeted towards researchers in biochemistry, molecular and cell biology, pharmacology, and cancer. This thematic volume discusses Eukaryotic RNases and their partners in RNA degradation and biogenesis. Key features: \* Contributions from leading auth

[The Enzymes] Eukaryotic RNases and thei
โœ Kang, Hara ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Elsevier ๐ŸŒ English โš– 224 KB

This special volume of *The Enzymes* is targeted towards researchers in biochemistry, molecular and cell biology, pharmacology, and cancer. This thematic volume discusses Eukaryotic RNases and their partners in RNA degradation and biogenesis. Key features: \* Contributions from leading auth